1. Home
  2. ZURA vs RELL Comparison

ZURA vs RELL Comparison

Compare ZURA & RELL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZURA
  • RELL
  • Stock Information
  • Founded
  • ZURA 2022
  • RELL 1947
  • Country
  • ZURA United States
  • RELL United States
  • Employees
  • ZURA N/A
  • RELL N/A
  • Industry
  • ZURA Biotechnology: Biological Products (No Diagnostic Substances)
  • RELL Electronic Components
  • Sector
  • ZURA Health Care
  • RELL Technology
  • Exchange
  • ZURA Nasdaq
  • RELL Nasdaq
  • Market Cap
  • ZURA 137.2M
  • RELL 149.6M
  • IPO Year
  • ZURA N/A
  • RELL N/A
  • Fundamental
  • Price
  • ZURA $4.59
  • RELL $10.52
  • Analyst Decision
  • ZURA Buy
  • RELL
  • Analyst Count
  • ZURA 8
  • RELL 0
  • Target Price
  • ZURA $10.43
  • RELL N/A
  • AVG Volume (30 Days)
  • ZURA 591.5K
  • RELL 76.3K
  • Earning Date
  • ZURA 11-07-2025
  • RELL 10-08-2025
  • Dividend Yield
  • ZURA N/A
  • RELL 2.24%
  • EPS Growth
  • ZURA N/A
  • RELL N/A
  • EPS
  • ZURA N/A
  • RELL 0.01
  • Revenue
  • ZURA N/A
  • RELL $209,791,000.00
  • Revenue This Year
  • ZURA N/A
  • RELL $4.72
  • Revenue Next Year
  • ZURA N/A
  • RELL $14.93
  • P/E Ratio
  • ZURA N/A
  • RELL $875.18
  • Revenue Growth
  • ZURA N/A
  • RELL 6.17
  • 52 Week Low
  • ZURA $0.97
  • RELL $7.57
  • 52 Week High
  • ZURA $4.85
  • RELL $15.51
  • Technical
  • Relative Strength Index (RSI)
  • ZURA 69.93
  • RELL 49.96
  • Support Level
  • ZURA $3.34
  • RELL $9.96
  • Resistance Level
  • ZURA $3.73
  • RELL $10.82
  • Average True Range (ATR)
  • ZURA 0.30
  • RELL 0.44
  • MACD
  • ZURA 0.04
  • RELL -0.07
  • Stochastic Oscillator
  • ZURA 98.06
  • RELL 56.15

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

About RELL Richardson Electronics Ltd.

Richardson Electronics Ltd provides engineered solutions, power grid, and microwave tubes and related consumables, power conversion, RF and microwave components, high-value flat panel detector solutions, replacement parts, tubes, and service training for diagnostic imaging equipment and customized display solutions. The company's segment includes Power and Microwave Technologies, Green Energy Solutions, Canvys, and Healthcare. The company generates the majority of its revenue from the Power and Microwave Technologies segment, which includes the power grid and microwave tube business and RF, Wireless and Power technologies.

Share on Social Networks: